Why the study?
Does an antitachycardia pacemaker reliably end tachycardia episodes in patients with supraventricular tachycardia?
Population
n=22 patients with supraventricular tachycardia, selected after detailed evaluation and testing of a…
Design
Cohort
Follow-up
mean 57.3 (range 19-76) months
Authors
Loading...
May support palliative SVT termination in selected patients; leaves open long-term safety versus ablation in contemporary practice.
Does an antitachycardia pacemaker reliably end tachycardia episodes in patients with supraventricular tachycardia?
Antitachycardia pacing is an acceptable long-term palliative option for selected patients with supraventricular tachycardia, though many still require drug therapy and curative techniques have decreased its need.
Connelly et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: